Histone cluster 1 H1T inhibitors are a category of chemical compounds that interact with the histone proteins in chromatin, specifically targeting the H1 histone subtype, known as H1T. Histones are fundamental components of chromatin, which is the complex of DNA and protein found in the nucleus of eukaryotic cells. The H1 histones, sometimes referred to as linker histones, play a critical role in chromatin structure by binding to the nucleosome and stabilizing higher-order chromatin structures. The H1T subtype of histones is unique in that it is expressed primarily in specific cell types and developmental stages, particularly during spermatogenesis, and is involved in regulating chromatin dynamics. Inhibitors of histone cluster 1 H1T are molecules designed to modulate the interaction between H1T histones and chromatin, thus influencing chromatin compaction, transcription regulation, and the overall organization of the genome.
These inhibitors typically work by interfering with the binding activity of H1T to the nucleosome or by altering its structural conformation, which can lead to changes in chromatin accessibility and transcriptional activity. Since chromatin organization is directly tied to gene expression and the maintenance of genomic integrity, the modulation of H1T histones can have broad implications on DNA processes such as replication and repair. Histone H1T inhibitors are valuable tools in research settings for studying chromatin architecture, epigenetic regulation, and the specific roles that different histone variants play in gene expression. By focusing on the modulation of histone H1T activity, these inhibitors provide insight into the finer details of chromatin behavior and its influence on cellular processes, contributing to a deeper understanding of gene regulation and chromatin dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially altering chromatin structure and impacting H1.6 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Another HDAC inhibitor, might affect chromatin conformation and thereby H1.6 levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor which might indirectly alter H1.6 expression by changing DNA methylation patterns. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor which may influence the chromatin structure and H1.6 expression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
By inhibiting HDAC, it can change chromatin dynamics and potentially the expression of H1.6. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
G9a histone methyltransferase inhibitor; could influence chromatin marks and H1.6 expression. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Inhibits histone methyltransferases, potentially influencing H1.6 levels. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor; may alter chromatin structure and H1.6 expression indirectly. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
HDAC inhibitor, potentially altering chromatin structure and impacting H1.6 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Another HDAC inhibitor, might affect chromatin conformation and thereby H1.6 levels. | ||||||